A third of the clinical trial results that federal regulators reviewed to approve drugs made by large pharmaceutical companies in 2012 were never publicly reported, according to a new study that grades companies on their transparency.That's upstream. I think we had downstream last week...
As many as a third of drug meta-analyses are written by pharma industry employees.They bias the data pool, the experimental protocols, they restrict patient pools, skew the conclusions and then the secondary analysis, too.
Yeah this is a big problem for us.
Drug companies are just about the only people interested in our illness.
